(Q53120583)

11 May 2018

title

Pediatric Non-alcoholic Fatty Liver Disease. (English)

1 reference

11 May 2018

non-alcoholic fatty liver

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Vikas Uppal

1

1 reference

11 May 2018

Sana Mansoor

series ordinal

2

1 reference

11 May 2018

Katryn N Furuya

series ordinal

3

1 reference

11 May 2018

publication date

1 May 2016

1 reference

11 May 2018

Current gastroenterology reports

published in

1 reference

11 May 2018

volume

18

1 reference

11 May 2018

issue

5

1 reference

11 May 2018

page(s)

24

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s11894-016-0498-9

exact match

0 references

cites work

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Pediatric fatty liver disease: role of ethnicity and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Obese children with steatohepatitis can develop cirrhosis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Advances in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Heritability of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

A feed-forward loop amplifies nutritional regulation of PNPLA3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Obesity, fatty liver disease and intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Nonalcoholic fatty liver disease in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Nonalcoholic Steatohepatitis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Nonalcoholic fatty liver disease: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Hepatocellular ballooning in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Application and limitations of transient liver elastography in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Assessment of hepatic fibrosis with magnetic resonance elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Magnetic resonance elastography of liver: technique, analysis, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-016-0498-9

A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

21 January 2018

1 reference

12 December 2020

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

12 December 2020

Prevalence of fatty liver in a general population of Okinawa, Japan

1 reference

12 December 2020

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

1 reference

12 December 2020

The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study

1 reference

12 December 2020

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

1 reference

12 December 2020

Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children

1 reference

12 December 2020

Pediatric non-alcoholic fatty liver disease: New insights and future directions

1 reference

12 December 2020

Pathology of nonalcoholic fatty liver disease

1 reference

12 December 2020

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

1 reference

12 December 2020

Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents.

1 reference

12 December 2020

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

1 reference

12 December 2020

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

12 December 2020

Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

1 reference

12 December 2020

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

1 reference

12 December 2020

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

1 reference

12 December 2020

Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee

1 reference

12 December 2020

Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease

1 reference

12 December 2020

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study

1 reference

12 December 2020

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease

1 reference

12 December 2020

Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.

1 reference

12 December 2020

Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial

1 reference

12 December 2020

Editorial: From Multiple Hits to Multiple Therapeutic Targets of Non-Alcoholic Fatty Liver Disease

1 reference

12 December 2020

10.1007/S11894-016-0498-9

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

27086005

1 reference

11 May 2018